Trial intelligence / Profile preview

Fulvestrant maintenance after first-line chemotherapy in HR+ advanced breast cancer

NCT02000193Phase 2Unknown

Sponsor
Sun Yat-sen University
Start
Nov 2013
Primary completion
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fulvestrant in breast cancer, sponsored by Sun Yat-sen University. Status: unknown.

02

Drugs

fulvestrant
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT02000193.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02000193.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call